Drug‐Eluting or Bare‐Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization

BACKGROUND: New‐generation drug‐eluting stents (DES) reduce target‐vessel revascularization compared with bare‐metal stents (BMS), and recent data suggest that DES have the potential to decrease the risk of myocardial infarction and cardiovascular mortality. We evaluated the treatment effect of DES...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccolo, Raffaele, Bonaa, Kaare H., Efthimiou, Orestis, Varenne, Olivier, Urban, Philip, Kaiser, Christoph, Räber, Lorenz, de Belder, Adam, Remkes, Wouter, van’t Hof, Arnoud W. J., Stankovic, Goran, Lemos, Pedro A., Wilsgaard, Tom, Reifart, Jörg, Rodriguez, Alfredo E., Ribeiro, Expedito E., Serruys, Patrick W. J. C., Abizaid, Alex, Sabaté, Manel, Byrne, Robert A., de la Torre Hernandez, Jose M., Wijns, William, Esposito, Giovanni, Jüni, Peter, Windecker, Stephan, Valgimigli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751874/
https://www.ncbi.nlm.nih.gov/pubmed/34622669
http://dx.doi.org/10.1161/JAHA.120.018828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751874/
https://www.ncbi.nlm.nih.gov/pubmed/34622669
http://dx.doi.org/10.1161/JAHA.120.018828

Ejemplares similares